BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24975811)

  • 1. Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.
    Donis RO; ; Davis CT; Foust A; Hossain MJ; Johnson A; Klimov A; Loughlin R; Xu X; Tsai T; Blayer S; Trusheim H; Colegate T; Fox J; Taylor B; Hussain A; Barr I; Baas C; Louwerens J; Geuns E; Lee MS; Venhuizen O; Neumeier E; Ziegler T
    Vaccine; 2014 Nov; 32(48):6583-90. PubMed ID: 24975811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
    Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones.
    Suphaphiphat P; Whittaker L; De Souza I; Daniels RS; Dormitzer PR; McCauley JW; Settembre EC
    Vaccine; 2016 Jul; 34(32):3641-8. PubMed ID: 27219338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor.
    Chu C; Lugovtsev V; Lewis A; Betenbaugh M; Shiloach J
    Vaccine; 2010 Oct; 28(44):7193-201. PubMed ID: 20800699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
    Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.
    Nakamura K; Harada Y; Takahashi H; Trusheim H; Bernhard R; Hamamoto I; Hirata-Saito A; Ogane T; Mizuta K; Konomi N; Konomi Y; Asanuma H; Odagiri T; Tashiro M; Yamamoto N
    Vaccine; 2019 Oct; 37(43):6526-6534. PubMed ID: 31500967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host cell-mediated variation in H3N2 influenza viruses.
    Katz JM; Naeve CW; Webster RG
    Virology; 1987 Feb; 156(2):386-95. PubMed ID: 3811239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses.
    Meyer WJ; Wood JM; Major D; Robertson JS; Webster RG; Katz JM
    Virology; 1993 Sep; 196(1):130-7. PubMed ID: 8356790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
    Kuwahara T; Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Takahashi H; Suzuki N; Kawaoka Y; Watanabe S; Odagiri T
    Jpn J Infect Dis; 2018 May; 71(3):234-238. PubMed ID: 29709975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds.
    Harada Y; Takahashi H; Trusheim H; Roth B; Mizuta K; Hirata-Saito A; Ogane T; Odagiri T; Tashiro M; Yamamoto N
    Influenza Other Respir Viruses; 2020 Mar; 14(2):204-209. PubMed ID: 31651085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7.
    Hamamoto I; Takaku H; Tashiro M; Yamamoto N
    PLoS One; 2013; 8(3):e59892. PubMed ID: 23555825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production.
    Abdoli A; Soleimanjahi H; Jamali A; Mehrbod P; Gholami S; Kianmehr Z; Feizi N; Saleh M; Bahrami F; Mokhtari-Azad T; Abdoli M; Kheiri MT
    Biotechnol Lett; 2016 Jun; 38(6):941-8. PubMed ID: 26945752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
    Hussain AI; Cordeiro M; Sevilla E; Liu J
    Vaccine; 2010 May; 28(22):3848-55. PubMed ID: 20307595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual.
    Katz JM; Webster RG
    Virology; 1988 Aug; 165(2):446-56. PubMed ID: 3407150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
    Kim EH; Kwon HI; Park SJ; Kim YI; Si YJ; Lee IW; Kim SM; Kim SI; Ahn DH; Choi YK
    J Microbiol Biotechnol; 2018 Jun; 28(6):997-1006. PubMed ID: 29642288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells.
    Katz JM; Webster RG
    J Gen Virol; 1992 May; 73 ( Pt 5)():1159-65. PubMed ID: 1588320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.
    Parker L; Wharton SA; Martin SR; Cross K; Lin Y; Liu Y; Feizi T; Daniels RS; McCauley JW
    J Gen Virol; 2016 Jun; 97(6):1333-1344. PubMed ID: 26974849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.
    Lekcharoensuk P; Wiriyarat W; Petcharat N; Lekcharoensuk C; Auewarakul P; Richt JA
    Vaccine; 2012 Feb; 30(8):1453-9. PubMed ID: 22230579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
    Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
    Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.